BAC
Bank of America Corporation
BAC has the edge over NRIM overall, supported by stronger fundamentals and stronger modeled upside.
NRIM
Northrim BanCorp, Inc.
NRIM trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
NRIM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
NRIM's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like NRIM.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
NRIM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.4x | $18.20 | -24% |
| Fair | 8.8x | $21.73 | -9.7% |
| Forward | 9.2x | $24.05 | — |
| Current | 9.7x | $24.05 | — |
| Expensive | 11x | $28.11 | +17% |
Historical ranges are pointers, not guarantees.
NRIM has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over NRIM on the outlook, with more favorable profitability expectations.
NRIM Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for NRIM, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
NRIM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.63 | +6.3% |
| Q3 2026 | $2.47 | -12% |
| Q2 2026 | $3.04 | +52% |
| Q1 2026 | $2.88 | +53% |
| Q4 2025 | $2.87 | +73% |
| Q3 2025 | $2.80 | +90% |
| Q2 2025 | $2.00 | +39% |
| Q1 2025 | $1.88 | +47% |
| Q4 2024 | $1.66 | +48% |
NRIM earned $2.47 per share over the past year, down 12% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
NRIM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $59.6M | -10% |
| Q2 2026 | $53.9M | +7.2% |
| Q1 2026 | $49.5M | +8.9% |
| Q4 2025 | $51.7M | +18% |
| Q3 2025 | $66.6M | +65% |
| Q2 2025 | $50.2M | +37% |
| Q1 2025 | $45.5M | +33% |
| Q4 2024 | $43.9M | +32% |
NRIM's revenue is growing: $60M last quarter, down 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | -21 points |
| Q2 2026 | 38% | +6.1 points |
| Q1 2026 | 36% | -2.4 points |
| Q4 2025 | 32% | +1.8 points |
| Q3 2025 | 52% | +23 points |
| Q2 2025 | 31% | -0.2 points |
| Q1 2025 | 39% | +8 points |
| Q4 2024 | 30% | +5.2 points |
NRIM has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
NRIM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$14.4M | -116% |
| Q2 2026 | $39.5M | +$44.2M |
| Q1 2026 | $24.3M | +49% |
| Q4 2025 | $32.3M | -12% |
| Q3 2025 | $89.9M | +$90.3M |
| Q2 2025 | -$4.7M | +$34.2M |
| Q1 2025 | $16.3M | +$22.9M |
| Q4 2024 | $36.5M | -26% |
NRIM has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over NRIM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
NRIM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +33.2K shares |
| 1 year | +0.3% | +75K shares |
| 3 years | +0.3% | +78K shares |
| 5 years | -9.9% | -2.5M shares |
| Available history | -17% | -4.7M shares |
NRIM has 23M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $1,000 |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $788,000 |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
NRIM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2019 | -0.4x | Net Cash |
NRIM has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like NRIM.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
NRIM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.9 | Neutral |
| Stochastic | 18.0 | Oversold |
NRIM's weekly RSI is 44 (neutral) and its Stochastic is 18 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
NRIM PE vs Financial Services Sector
| Metric | NRIM | Sector median | Relative |
|---|---|---|---|
| PE | 9.7x | 13x | 25% below |
| PE % | 62 | 63 | 1 pt below |
NRIM has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
NRIM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $24.1 | 0.2% below |
| 20 week MA | $25.6 | 6% below |
| 50 week MA | $25.3 | 4.9% below |
| 100 week MA | $23.3 | 3.4% above |
| 200 week MA | $18.2 | 32% above |
NRIM has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over NRIM on returns for 2026, with the stronger performance.
NRIM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.49 | $8.24 | -13% |
| 2021 | $8.24 | $10.7 | +30% |
| 2022 | $10.7 | $13.7 | +27% |
| 2023 | $13.7 | $14.3 | +4.7% |
| 2024 | $14.3 | $19.3 | +35% |
| 2025 | $19.3 | $27.1 | +41% |
| 2026 YTD | $27.1 | $24.1 | -11% |
NRIM has finished higher in five of the last six years. It's down 11% so far in 2026.